16.01.2014 • Topics

Helsinn Reaps Benefits of Cytotoxic Molecule Demand

Company

Helsinn Chemicals SA

Via Industria 24
6710 Biasca
Switzerland

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

most read

Topics • Chemistry

US Tariffs Fatal for European Pharma

Trump's tariff policy is a considerable burden and a break with previous practice.

Topics • Chemistry

Q1 2025 Chemical Industry: Diverging Trends

The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

Topics • Pharma

ISPE Good Practice Guide: Validation 4.0

The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Topics • Pharma

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma

Part 1: Building a Business Case for Pharma 4.0

20 Years of CHEManager International

Incredible but true: CHEManager International is celebrating its 20th anniversary!